Joseph A. Pierro

Carotid MR Angiography: Phase II Study of Safety and Efficacy for MS-325

David A. Bluemke, Arthur E. Stillman, Kostaki G. Bis et al. · Radiology · 2001 · 82 citations

Pharmacokinetics, safety, and tolerability of gadoversetamide injection (OptiMARK) in subjects with central nervous system or liver pathology and varying degrees of renal function

Suzanne K. Swan, James F. Baker, Richard Free et al. · Journal of Magnetic Resonance Imaging · 1999 · 54 citations

Imaging Agent, Pharmacotherapy, Gadolinium Pharmacokinetics +17

Contrast Dose-to-Creatinine Clearance Ratio as a Potential Indicator of Risk for Radiocontrast-Induced Nephropathy

Paul Sherwin, Richard Cambron, Judith A. Johnson et al. · Investigative Radiology · 2005 · 53 citations

A multicenter, randomized, double‐blind study to evaluate the safety, tolerability, and efficacy of OptiMARK (gadoversetamide injection) compared with Magnevist (gadopentetate dimeglumine) in patients with liver pathology: Results of a phase III clinical trial

Daniel L. Rubin, Terry S. Desser, Richard C. Semelka et al. · Journal of Magnetic Resonance Imaging · 1999 · 44 citations

Imaging Agent, Interventional Radiology, Suspected Liver Pathology +22

Left retrocaval ureter associated with left inferior vena cava.

Joseph A. Pierro, M. Soleimanpour, J L Bory · American Journal of Roentgenology · 1990 · 34 citations

Urological Research, Urology, Surgical Pathology +8